Skip to main content
Top
Published in: Metabolic Brain Disease 2/2016

01-04-2016 | Original Article

Behavioral effects of citrus paradisi in rats

Authors: Neelam Mallick, Rafeeq Alam Khan

Published in: Metabolic Brain Disease | Issue 2/2016

Login to get access

Abstract

Anxiety and depression adversely affect behavior though these conditions may be handled through environmental and dietary changes. Diet rich in flavonoids and vitamins may support reducing anxiety and depression. Depression is most common but serious illness making life miserable; however the usage of dietary and herbal complements to treat anxiety and depression had been grown by the time. The purpose of this investigation was to characterize the behavioral properties of Citrus paradisi in rats at diverse doses i.e. 0.1, 0.3 and 0.5 ml/kg. Anxiolytic and antidepressant actions were particularly measured twice in 15 days through elevated plus maze, open field and forced swimming tests. C. paradisi, revealed increase in the locomotor activity and the exploratory skills of the animals, as assessed in the open-field. Indeed C. paradisi had a strong anxiolytic effect in elevated plus-maze, as assessed by an augmented number of entries and the proportion of time spent in the open arms. Moreover there was decline in duration of immobility and rise in duration of climbing during forced swimming test. At the tested doses these results suggest that C. paradisi have the potential to exert a range of CNS-mediated biological activities and thus encourage more investigations in this field.
Literature
go back to reference Alves R, de Carvalho JGB, Benedito MCA (2005) High and low rearing subgroups of rats selected in the open field differ in the activity of K+ − stimulated p-nitrophenylphosphatase in the hippocampus. Brain Res 1058(1–2):178–182. Alves R, de Carvalho JGB, Benedito MCA (2005) High and low rearing subgroups of rats selected in the open field differ in the activity of K+ − stimulated p-nitrophenylphosphatase in the hippocampus. Brain Res 1058(1–2):178–182.
go back to reference Arieti S, Bemporad J (1980) The psychological organization of depression. Am J Psychiatr 137:1360–1365CrossRefPubMed Arieti S, Bemporad J (1980) The psychological organization of depression. Am J Psychiatr 137:1360–1365CrossRefPubMed
go back to reference Budzynska B, Boguszewska-Czubara A, Kruk-Slomka M, Skalicka- Woziniak K, Michalak A, Musik I, Biala G, Glowniak K (2013) Effects of imperatorin on nicotine induced anxiety and memory related responses and oxidative stress in mice. Physiol Behav 122:46–55. Budzynska B, Boguszewska-Czubara A, Kruk-Slomka M, Skalicka- Woziniak K, Michalak A, Musik I, Biala G, Glowniak K (2013) Effects of imperatorin on nicotine induced anxiety and memory related responses and oxidative stress in mice. Physiol Behav 122:46–55.
go back to reference Carbajal D, Ravelo Y, Molina V, Mas R, Arruzazabala ML (2009) D-004 a lipid extract from royal palm fruit, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice. Pharmacol Biochem Behav 92:465–468CrossRefPubMed Carbajal D, Ravelo Y, Molina V, Mas R, Arruzazabala ML (2009) D-004 a lipid extract from royal palm fruit, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice. Pharmacol Biochem Behav 92:465–468CrossRefPubMed
go back to reference Council NR (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, pp. 1–7 Council NR (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, pp. 1–7
go back to reference Czech Donald A (2002) A simple integrated circuit device for measuring distances traveled and determining speed in open-field environments. Pharmacol Biochem Behav 72(1–2):73–75CrossRefPubMed Czech Donald A (2002) A simple integrated circuit device for measuring distances traveled and determining speed in open-field environments. Pharmacol Biochem Behav 72(1–2):73–75CrossRefPubMed
go back to reference Evans DL, Charney DS, Lewis L, Golden JM, Krishnan KRR, Nemeroff CB (2005) Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 58:175–189CrossRefPubMed Evans DL, Charney DS, Lewis L, Golden JM, Krishnan KRR, Nemeroff CB (2005) Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 58:175–189CrossRefPubMed
go back to reference Griebel G, Perrault G, Tan S, Schoemaker H, Sanger DJ (1999) Pharmacological studies on synthetic flavonoids: comparison with diazepam. Neuropharmacology 38:965–977CrossRefPubMed Griebel G, Perrault G, Tan S, Schoemaker H, Sanger DJ (1999) Pharmacological studies on synthetic flavonoids: comparison with diazepam. Neuropharmacology 38:965–977CrossRefPubMed
go back to reference Gupta V, Bansal P, Kumar P, Kaur G (2010a) Pharmacopoeial standards and pharmacognostical studies of leaves of citrus paradisi Var. Foster. Res J Pharmacog Phytochem 2:140–143 Gupta V, Bansal P, Kumar P, Kaur G (2010a) Pharmacopoeial standards and pharmacognostical studies of leaves of citrus paradisi Var. Foster. Res J Pharmacog Phytochem 2:140–143
go back to reference Gupta V, Bansal P, Kumar P, Shri R (2010b) Anxiolytic and antidepressant activities of different extracts from citrus paradisi var. Duncan Asian. J Pharm Clin Res 3(2):98–100 Gupta V, Bansal P, Kumar P, Shri R (2010b) Anxiolytic and antidepressant activities of different extracts from citrus paradisi var. Duncan Asian. J Pharm Clin Res 3(2):98–100
go back to reference Gupta V, Bansal P, Niazi J, Kaur G (2010c) Anti-anxiety activity of citrus paradisi var. star ruby extracts. Int J PharmTech Res 2(3):1655–1657 Gupta V, Bansal P, Niazi J, Kaur G (2010c) Anti-anxiety activity of citrus paradisi var. star ruby extracts. Int J PharmTech Res 2(3):1655–1657
go back to reference Gupta V, Kohli K, Ghaiye P, Bansal P, Lather A (2011) Pharmacological potentials of citrus paradisi – an overview. Int J Phytotherapy Res 1(1):8–17 Gupta V, Kohli K, Ghaiye P, Bansal P, Lather A (2011) Pharmacological potentials of citrus paradisi – an overview. Int J Phytotherapy Res 1(1):8–17
go back to reference Gureje O, Von Korff M, Simon GE, Gater R (1998) Persistent pain and wellbeing: a World Health Organization study in primary care. JAMA 280:147–151CrossRefPubMed Gureje O, Von Korff M, Simon GE, Gater R (1998) Persistent pain and wellbeing: a World Health Organization study in primary care. JAMA 280:147–151CrossRefPubMed
go back to reference Herskin MS, Jensen KH (2002) Effects of open field testing and associated handling v. handling alone on the adrenocortical reactivity of piglets around weaning. Anim Sci 74:485–491 Herskin MS, Jensen KH (2002) Effects of open field testing and associated handling v. handling alone on the adrenocortical reactivity of piglets around weaning. Anim Sci 74:485–491
go back to reference Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54(1):21–30CrossRefPubMed Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54(1):21–30CrossRefPubMed
go back to reference Kennett GA, Dourish CT, Curzon G (1987) Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur J Pharmacol 134(3):265–274CrossRefPubMed Kennett GA, Dourish CT, Curzon G (1987) Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur J Pharmacol 134(3):265–274CrossRefPubMed
go back to reference Komiya M, Takeuchi T, Harada E (2006) Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice. Behav Brain Res 172:240–249CrossRefPubMed Komiya M, Takeuchi T, Harada E (2006) Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice. Behav Brain Res 172:240–249CrossRefPubMed
go back to reference Kumar S, Sharma A (2005) Anti-anxiety activity studies of various extracts of turnera aphrodisiaca ward. J Herb Pharmacother 5:13–21CrossRefPubMed Kumar S, Sharma A (2005) Anti-anxiety activity studies of various extracts of turnera aphrodisiaca ward. J Herb Pharmacother 5:13–21CrossRefPubMed
go back to reference Lather A, Gupta V, Chaudhary AK, Singh R, Bansal P, Ghaiye P, Bansal R (2012) In vitro evaluation of antimicrobial activity of Kutajghan Vati - an Ayurvedic Formulation Pak. J Pharm Sci 25(3):693–696 Lather A, Gupta V, Chaudhary AK, Singh R, Bansal P, Ghaiye P, Bansal R (2012) In vitro evaluation of antimicrobial activity of Kutajghan Vati - an Ayurvedic Formulation Pak. J Pharm Sci 25(3):693–696
go back to reference Mansouri MT, SoltaniM NB, Farbood Y, Mashak A, Sarkaki A (2014) A possible mechanism for the anxiolytic-like effect of gallic acid in the rat elevated plus maze. Pharmacol Biochem Behav 117:40–46CrossRefPubMed Mansouri MT, SoltaniM NB, Farbood Y, Mashak A, Sarkaki A (2014) A possible mechanism for the anxiolytic-like effect of gallic acid in the rat elevated plus maze. Pharmacol Biochem Behav 117:40–46CrossRefPubMed
go back to reference More S, Sathe S, Sonawane A, Jadhav A, Kadam V (2013) Citrus paradisi: an overview, Indo American. J Pharm Res 3(10):8070–8077 More S, Sathe S, Sonawane A, Jadhav A, Kadam V (2013) Citrus paradisi: an overview, Indo American. J Pharm Res 3(10):8070–8077
go back to reference Novas ML, Wolfman C, Jorge H, De Robertis E (1988) Proconvulsantand ‘anxiogenic’ effects of n-butyl β carboline-3-carboxylate, an endogenous benzodiazepine binding inhibitor from brain. Pharmacol Biochem Behav 30:331–336CrossRefPubMed Novas ML, Wolfman C, Jorge H, De Robertis E (1988) Proconvulsantand ‘anxiogenic’ effects of n-butyl β carboline-3-carboxylate, an endogenous benzodiazepine binding inhibitor from brain. Pharmacol Biochem Behav 30:331–336CrossRefPubMed
go back to reference Palazzolo E, Laudicina VA, Germanà MA (2013) Current and potential use of citrus essential oils. Curr Org Chem 17:3042–3049CrossRef Palazzolo E, Laudicina VA, Germanà MA (2013) Current and potential use of citrus essential oils. Curr Org Chem 17:3042–3049CrossRef
go back to reference Pellow S, Sandra FE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze:anovel test of anxiety in the rat. Pharmacol Biochem Behav 24(3):525–529CrossRefPubMed Pellow S, Sandra FE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze:anovel test of anxiety in the rat. Pharmacol Biochem Behav 24(3):525–529CrossRefPubMed
go back to reference Petit-Demouliere B, Chenu F, Bourin M (2005) Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 177:245–255CrossRefPubMed Petit-Demouliere B, Chenu F, Bourin M (2005) Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 177:245–255CrossRefPubMed
go back to reference Pine DS, Wasserman GA, Workman SB (1999) Memory and anxiety in pre-pubertal boys at risk for delinquency. J Am Acad Child Adolesc Psychiatry 38:1024–1031CrossRefPubMed Pine DS, Wasserman GA, Workman SB (1999) Memory and anxiety in pre-pubertal boys at risk for delinquency. J Am Acad Child Adolesc Psychiatry 38:1024–1031CrossRefPubMed
go back to reference Porsolt RD, Anton G, Blavet N, Jalfre M (1987) Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47(4):379–391CrossRef Porsolt RD, Anton G, Blavet N, Jalfre M (1987) Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47(4):379–391CrossRef
go back to reference Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730–732CrossRefPubMed Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730–732CrossRefPubMed
go back to reference Prut L, Belzung (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463(1–3):3–33 Prut L, Belzung (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463(1–3):3–33
go back to reference Sadock BJ, Sadock VA, Sadock’s K (2003) Synopsis of psychiatry— behavioral sciences/clinical psychiatry, 9th edn. Lippincott Williams and Wilkins, Philadelphia Sadock BJ, Sadock VA, Sadock’s K (2003) Synopsis of psychiatry— behavioral sciences/clinical psychiatry, 9th edn. Lippincott Williams and Wilkins, Philadelphia
go back to reference Soderpalm B, Svensson L, Hulthe P, Johannessen K, Engel JA (1991) Evidence for a role for dopamine in the diazepam locomotor stimulating effect. Psychopharmacology 104:97–102CrossRefPubMed Soderpalm B, Svensson L, Hulthe P, Johannessen K, Engel JA (1991) Evidence for a role for dopamine in the diazepam locomotor stimulating effect. Psychopharmacology 104:97–102CrossRefPubMed
go back to reference Spinella M (2001) Herbal medicines and epilepsy: the potential for benefit and adverse effects. Epilepsy Behav 2:524–532CrossRefPubMed Spinella M (2001) Herbal medicines and epilepsy: the potential for benefit and adverse effects. Epilepsy Behav 2:524–532CrossRefPubMed
go back to reference Taiwo Adefunmilayo E, Leite Franco B, Lucena Greice M, Barros M, Silveira D, Silva Monica V, Ferreira Vania M (2012) Anxiolytic and antidepressant-like effects of Melissa officinalis (lemon balm) extract in rats: influence of administration and gender. Indian J Pharmacol 44:189–192CrossRefPubMedPubMedCentral Taiwo Adefunmilayo E, Leite Franco B, Lucena Greice M, Barros M, Silveira D, Silva Monica V, Ferreira Vania M (2012) Anxiolytic and antidepressant-like effects of Melissa officinalis (lemon balm) extract in rats: influence of administration and gender. Indian J Pharmacol 44:189–192CrossRefPubMedPubMedCentral
go back to reference Thase ME, Howland RH (1995) Biological processes in depression: an update and integration. In: Beckham EE, Leber WR (eds) Handbook of depression, 2nd edn. Guilford, New York, pp. 213–279 Thase ME, Howland RH (1995) Biological processes in depression: an update and integration. In: Beckham EE, Leber WR (eds) Handbook of depression, 2nd edn. Guilford, New York, pp. 213–279
go back to reference The World Health Report (2001) Mental health: new understanding new hope. WHO, Geneva The World Health Report (2001) Mental health: new understanding new hope. WHO, Geneva
go back to reference Wilner P (1984) The validity of animal models of depression. Psychopharmacology 83:1–16CrossRef Wilner P (1984) The validity of animal models of depression. Psychopharmacology 83:1–16CrossRef
go back to reference Wolfman C, Viola H, Paladini A, Dajas F, Medina JH (1994) Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from passiflora coerulea. Pharmacol Biochem Behav 47:1–4CrossRefPubMed Wolfman C, Viola H, Paladini A, Dajas F, Medina JH (1994) Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from passiflora coerulea. Pharmacol Biochem Behav 47:1–4CrossRefPubMed
go back to reference Yang S-A, S-Kyung J, E-Jung L, C-Hyun S, In-Seon L (2010) Comparative study of the chemical composition and antioxidant activity of six essential oils and their components. Nat Prod Res 24:140–151CrossRefPubMed Yang S-A, S-Kyung J, E-Jung L, C-Hyun S, In-Seon L (2010) Comparative study of the chemical composition and antioxidant activity of six essential oils and their components. Nat Prod Res 24:140–151CrossRefPubMed
go back to reference Zhang ZJ (2004) Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci 75:1659–1699CrossRefPubMed Zhang ZJ (2004) Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci 75:1659–1699CrossRefPubMed
Metadata
Title
Behavioral effects of citrus paradisi in rats
Authors
Neelam Mallick
Rafeeq Alam Khan
Publication date
01-04-2016
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 2/2016
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-015-9754-1

Other articles of this Issue 2/2016

Metabolic Brain Disease 2/2016 Go to the issue